Theratechnologies Inc. (TH) - Total Assets

Latest as of May 2025: CA$51.27 Million CAD ≈ $37.09 Million USD

Based on the latest financial reports, Theratechnologies Inc. (TH) holds total assets worth CA$51.27 Million CAD (≈ $37.09 Million USD) as of May 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See TH book value for net asset value and shareholders' equity analysis.

Theratechnologies Inc. - Total Assets Trend (1996–2024)

This chart illustrates how Theratechnologies Inc.'s total assets have evolved over time, based on quarterly financial data.

Theratechnologies Inc. - Asset Composition Analysis

Current Asset Composition (November 2024)

Theratechnologies Inc.'s total assets of CA$51.27 Million consist of 82.5% current assets and 17.6% non-current assets.

Asset Category	Amount (CAD)	% of Total Assets
Cash & Equivalents	CA$3.72 Million	11.1%
Accounts Receivable	CA$14.97 Million	28.1%
Inventory	CA$5.28 Million	9.9%
Property, Plant & Equipment	CA$1.26 Million	2.4%
Intangible Assets	CA$7.57 Million	14.2%
Goodwill	CA$0.00	0.0%

Asset Composition Trend (1996–2024)

This chart illustrates how Theratechnologies Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Theratechnologies Inc. (TH) total market value.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Theratechnologies Inc.'s current assets represent 82.5% of total assets in 2024, an increase from 81.7% in 1996.
Cash Position: Cash and equivalents constituted 11.1% of total assets in 2024, down from 46.6% in 1996.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 0.0% in 1996.
Asset Diversification: The largest asset category is accounts receivable at 28.1% of total assets.

Theratechnologies Inc. Competitors by Total Assets

Key competitors of Theratechnologies Inc. based on total assets are shown below.

Company	Country	Total Assets
Argen-X F:1AE	Germany	€7.18 Billion
Tubize-Fin BR:TUB	Belgium	€1.93 Billion
BrightGene Bio Medical Technology C SHG:688166	China	CN¥5.38 Billion
Dashenlin Pharm Grp Co Ltd SHG:603233	China	CN¥26.08 Billion
Staidson Beijing Biopharma SHE:300204	China	CN¥1.26 Billion
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	China	CN¥6.64 Billion
Ardelyx Inc NASDAQ:ARDX	USA	$486.17 Million
Xiangxue Pharmaceutical SHE:300147	China	CN¥7.36 Billion

Theratechnologies Inc. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.84	1.10	1.90
Quick Ratio	0.65	1.00	1.14
Cash Ratio	0.01	0.00	0.00
Working Capital	CA$-6.15 Million	CA$5.34 Million	CA$30.29 Million

Theratechnologies Inc. - Advanced Valuation Insights

This section examines the relationship between Theratechnologies Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	19.46
Latest Market Cap to Assets Ratio	2.79
Asset Growth Rate (YoY)	-31.4%
Total Assets	CA$53.34 Million
Market Capitalization	$148.68 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Theratechnologies Inc.'s assets at a significant premium (2.79x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Theratechnologies Inc.'s assets decreased by 31.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Theratechnologies Inc. (1996–2024)

The table below shows the annual total assets of Theratechnologies Inc. from 1996 to 2024.

Year	Total Assets	Change
2024-11-30	CA$53.34 Million ≈ $38.59 Million	-31.41%
2023-11-30	CA$77.77 Million ≈ $56.26 Million	-16.61%
2022-11-30	CA$93.26 Million ≈ $67.46 Million	-21.77%
2021-11-30	CA$119.21 Million ≈ $86.24 Million	+19.04%
2020-11-30	CA$100.14 Million ≈ $72.44 Million	-14.81%
2019-11-30	CA$117.56 Million ≈ $85.04 Million	+5.66%
2018-11-30	CA$111.25 Million ≈ $80.48 Million	+87.65%
2017-11-30	CA$59.29 Million ≈ $42.89 Million	+50.36%
2016-11-30	CA$39.43 Million ≈ $28.52 Million	+5.27%
2015-11-30	CA$37.46 Million ≈ $27.10 Million	+31.39%
2014-11-30	CA$28.51 Million ≈ $20.62 Million	+21.82%
2013-11-30	CA$23.40 Million ≈ $16.93 Million	-36.02%
2012-11-30	CA$36.58 Million ≈ $26.46 Million	-28.57%
2011-11-30	CA$51.20 Million ≈ $37.04 Million	-27.14%
2010-11-30	CA$70.28 Million ≈ $50.84 Million	+6.98%
2009-11-30	CA$65.70 Million ≈ $47.52 Million	+50.69%
2008-11-30	CA$43.60 Million ≈ $31.54 Million	-41.52%
2007-11-30	CA$74.55 Million ≈ $53.93 Million	+66.97%
2006-11-30	CA$44.65 Million ≈ $32.30 Million	-2.79%
2005-11-30	CA$45.93 Million ≈ $33.23 Million	-19.74%
2004-11-30	CA$57.23 Million ≈ $41.40 Million	-21.47%
2003-11-30	CA$72.88 Million ≈ $52.72 Million	-18.83%
2002-11-30	CA$89.78 Million ≈ $64.95 Million	-0.66%
2001-11-30	CA$90.38 Million ≈ $65.38 Million	+64.34%
2000-11-30	CA$54.99 Million ≈ $39.78 Million	+198.81%
1999-11-30	CA$18.40 Million ≈ $13.31 Million	+48.00%
1998-11-30	CA$12.43 Million ≈ $9.00 Million	+46.24%
1997-11-30	CA$8.50 Million ≈ $6.15 Million	-47.68%
1996-11-30	CA$16.25 Million ≈ $11.76 Million	--

About Theratechnologies Inc.

TO:TH Canada Biotechnology

Market Cap

$148.68 Million

CA$205.53 Million CAD

Market Cap Rank

#17674 Global

#568 in Canada

Share Price

CA$4.47

Change (1 day)

-4.89%

52-Week Range

CA$3.20 - CA$4.70

All Time High

CA$58.28